Absorbable hemostats are medical devices designed to control bleeding during surgical procedures by promoting rapid coagulation at the site of injury or incision. These hemostats are bioabsorbable, meaning they are broken down and absorbed by the body over time, eliminating the need for removal after surgery.
The absorbable hemostats market consists of sales, by entities (organizations, sole traders and partnerships), of absorbable hemostats that are commonly used in various surgical disciplines to ensure hemostasis, minimize blood loss and facilitate better surgical outcomes. The primary users of absorbable hemostats include surgeons, operating room personnel and healthcare professionals across a wide range of specialties. These devices are typically used intraoperatively in situations where mechanical means of bleeding control, such as sutures or clamps, are insufficient or impractical.
The global absorbable hemostats market was valued at $2,360.67 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 5.00%.
Increasing Focus On Blood Loss Management
Increasing focus on blood loss management propelled the absorbable hemostats market growth in the historic period. Blood loss management encompasses strategies and interventions to prevent and control excessive bleeding during procedures like surgeries or organ transplants, ensuring patient safety and recovery. In organ transplantation, managing blood loss is crucial, as it minimizes complications and supports better outcomes. Absorbable hemostats play a key role in this process by reducing bleeding, lowering the need for transfusions, and enhancing patient recovery. For instance, in January 2024, according to Organ Procurement and Transplantation Network (OPTN), a US-based government department, there were 46,632 organ transplants performed by both living and deceased donors in 2023. This represents an 8.7% increase over 2022 and a 12.7% increase over 2021. Therefore, increasing focus on blood loss management fueled the absorbable hemostats market growth during previous years.
Innovations in Absorbable Hemostats With Focus On Plant-Based Cellulose Matrix Solutions
Major companies in the absorbable hemostats market are focusing on innovative wound care solutions that combine natural, biocompatible materials with advanced technological features such as plant-based cellulose matrix to enhance product efficacy, improve patient outcomes and gain a competitive edge in the growing demand for sustainable and effective healthcare solutions. A plant-based cellulose matrix in absorbable hemostats offers a natural, biocompatible solution that promotes rapid hemorrhage control, tissue regeneration and enhanced wound healing while being fully absorbable and biodegradable. For example, in April 2024, LifeScience PLUS, a US-based medical device manufacturer, launched DonorSeal, a 100% natural, plant-based cellulose matrix designed for donor site treatment. It rapidly controls hemorrhage, reduces blood loss and promotes wound healing by forming a translucent gel when it contacts blood, creating a moist wound environment essential for tissue regeneration. Key features include being fully absorbable, biodegradable, pH neutral, non-toxic and safe for all age groups, including patients on blood thinners, with no recurring bleeding or adhesion upon removal.
The global absorbable hemostats market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up 21.53% of the total market in 2023.
Absorbable Hemostats Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global absorbable hemostats market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for absorbable hemostats? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The absorbable hemostats market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider absorbable hemostats market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by application and by end-user.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the absorbable hemostats market.
- Global Market Size And Growth Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
- Market Segmentation Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
- Regional Market Size And Growth Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for absorbable hemostats providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Type: Thrombin-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats; Gelatin-Based Hemostats; Collagen-Based Hemostats; Other Types
- 2) By Application: Neurosurgery; Orthopedic Surgery; General Surgery; Reconstructive Surgery; Other Applications
- 3) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Other End-Users
- Companies Mentioned: Johnson & Johnson; Baxter International Inc.; Becton, Dickinson and Company (C. R. Bard, Inc.); Gelita AG; Samyang Holdings Corporation
- Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; absorbable hemostats indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.